Advertisement

Endocrine Testing and the Association Between Varicocele and Hypogonadism

  • Grace Yaguchi
  • Ali A. DabajaEmail author
Chapter

Abstract

Varicocele is a common condition resulting from an abnormal dilation of the pampiniform vein plexus within the spermatic cord. The exact pathophysiologic impact of varicocele on the testicular environment continues to be explored. The progressive testicular injury caused by varicocele may involve increased intratesticular temperature, increased oxidative stress, and the reflux of gonadotoxic renal and adrenal metabolites. There is increasing evidence that, in addition to spermatogenesis, production of testosterone by Leydig cells and the delivery of this hormone to the systemic blood stream may also be impacted by varicocele. While surgical repair of varicocele is most commonly performed for male infertility and leads to improvement in semen parameters in most men, new research indicates the correction of varicocele may also improve the function of Leydig cells, and, therefore, testosterone levels in hypogonadal men. Hypogonadism has been associated with erectile dysfunction, decreased sex drive, loss of muscle mass, and loss of bone composition. Currently, treatment of primary hypogonadism includes testosterone replacement therapy or use of GnRH agonist. Varicocele repair could treat hypogonadism by improving the function of Leydig cells while maintaining the homeostasis of the endocrine feedback system. Pre- and postsurgical endocrine testing should be incorporated in the evaluation of men in whom surgical correction of varicocele is considered. With careful selection and counseling, microsurgical varicocele repair may be offered to men with clinical varicocele and hypogonadism to improve their total serum testosterone.

Keywords

Varicocele Hypogonadism Testosterone Leydig cells Varicocelectomy 

References

  1. 1.
    Gorelick JI, Goldstein M. Loss of fertility in men with varicocele. Fertil Steril. 1993;59:613–6.CrossRefGoogle Scholar
  2. 2.
    Kacsoh B. Endocrine physiology. 5th ed. New York: McGraw-Hill; 2000.Google Scholar
  3. 3.
    Zwart AD, Iranmanesh A, Veldhuis JD. Disparate serum free testosterone concentrations and degrees of hypothalamo-pituitary-LH suppression are achieved by continuous versus pulsatile intravenous androgen replacement in men: a clinical experimental model of ketoconazole-induced reversible hypoandrogenemia with controlled testosterone add-back. J Clin Endocrinol Metab. 1997;82:2062–9.PubMedGoogle Scholar
  4. 4.
    Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl. 1989;10:366–71.CrossRefGoogle Scholar
  5. 5.
    Jarow JP, Zirkin BR. The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci. 2005;1061:208–20.CrossRefGoogle Scholar
  6. 6.
    Coviello AD, Bremner WJ, Matsumoto AM, et al. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl. 2004;25:931–8.CrossRefGoogle Scholar
  7. 7.
    Liu Z, Liu J, Shi X, Wang L, Yang Y, Tao M, Fu Q. Comparing calculated free testosterone with total testosterone for screening and diagnosing late-onset hypogonadism in aged males: a cross-sectional study. J Clin Lab Anal. 2016;31(5)  https://doi.org/10.1002/jcla.22073.CrossRefGoogle Scholar
  8. 8.
    Woolf PD, Hamill RW, McDonald JV, et al. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 1985;60:444–50.CrossRefGoogle Scholar
  9. 9.
    Chueh K, et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl. 2012;33(5):817–23.CrossRefGoogle Scholar
  10. 10.
    Bernie A, Scovell J, Ramasamy R. Comparison of questionnaires used for screening and symptom identification in hypogonadal men. Aging Male. 2014;17(4):195–8. PMID: 25247629.CrossRefGoogle Scholar
  11. 11.
    Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. JCEM. 2018;103(5):1715–44.PubMedGoogle Scholar
  12. 12.
    Mulhall J, Trost L, Brannigan R, et al. The evaluation and management of testosterone deficiency AUA guideline. J Urol. 2018;200(2):423–32.CrossRefGoogle Scholar
  13. 13.
    Wang C, Nieschlang E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur J Endocrinol. 2008;159:507–14.CrossRefGoogle Scholar
  14. 14.
    Buvat J, et al. Endocrine aspects of male sexual dysfunctions. J Sex Med. 2010;7:1627–56.CrossRefGoogle Scholar
  15. 15.
    Paduch D, Brannigan R, Fuchs E, Kim E, Marmar J, Sandlow J. Laboratory diagnosis of testosterone deficiency. Urology. 2014;83(5):980–8. PMID: 24548716.CrossRefGoogle Scholar
  16. 16.
    Crawford ED, et al. The association of time of day and serum testosterone concentration in a large screening population. BJU Int. 2007;100(3):509–13.CrossRefGoogle Scholar
  17. 17.
    Morgentaler A. Commentary: guideline for male testosterone therapy: a clinician’s perspective. J Clin Endocrinol Metab. 2007;92:416–7.CrossRefGoogle Scholar
  18. 18.
    Conners WP. Hypogonadism physiology, epidemiology, pathophysiology, evaluation. AUA University. Last updated 9/12/2017.Google Scholar
  19. 19.
    Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–72.CrossRefGoogle Scholar
  20. 20.
    Barbotin AL, Ballot C, Sigala J, et al. The serum inhibin B concentration and reference ranges in normozoospermia. Eur J Endocrinol. 2015;172(6):669–76.CrossRefGoogle Scholar
  21. 21.
    Anawalt BD. Approach to male infertility and induction of spermatogenesis. J Clin Endocrinol Metab. 2013;98(9):3532–42.CrossRefGoogle Scholar
  22. 22.
    Naughton C, Nangia AK, Agarwal A. Varicocele and male infertility: Part II. Pathophysiology of varicocele in male infertility. Hum Reprod Update. 2001;7:473–81.CrossRefGoogle Scholar
  23. 23.
    Sirvent JJ, Bernat R, Navarro MA, et al. Leydig cell in idiopathic varicocele. Eur Urol. 1990;17:257–61.CrossRefGoogle Scholar
  24. 24.
    Vakalopoulos I, Kampantais S, Lymperi S, et al. Should we expand the indications for varicocele treatment? Transl Androl Urol. 2017;6(5):931–42.  https://doi.org/10.21037/tau.2017.08.01.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Zheng YQ, Zhang XB, Zhou JQ, et al. The effects of artery-ligating and artery- preserving varicocelectomy on the ipsilateral testes in rates. Urology. 2008;72:1179–84.CrossRefGoogle Scholar
  26. 26.
    Gomaa MD, Motawaa MA, Al-Nashar AM, El-Sakka AI. Impact of subinguinal varicocelectomy on serum testosterone to estradiol ratio in male patients with infertility. Urology. 2018;117:70–7.  https://doi.org/10.1016/j.urology.2018.03.039. Epub 2018 Apr 6.CrossRefPubMedGoogle Scholar
  27. 27.
    Whelan P, Levine L. Effects of varicocelectomy on serum testosterone. Transl Androl Urol. 2016;5(6):866–76.  https://doi.org/10.21037/tau.2016.08.06.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Han H, Zhou XG, Qian XS, Feng SJ, Tian L, Zhang XD. Significant alterations of serum hormone levels in the spermatic vein plexus of patients with varicoceles. Andrologia. 2016;48(10):1108–12.  https://doi.org/10.1111/and.12546. Epub 2016 Feb 3. PMID: 26840997.CrossRefPubMedGoogle Scholar
  29. 29.
    Hayden RP, Tanrikut C. Testosterone and varicocele. Urol Clin N Am. 2016;43(2):223–32.CrossRefGoogle Scholar
  30. 30.
    Diemer T, Allen JA, Hales KH, et al. Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology. 2003;144:2882–91.CrossRefGoogle Scholar
  31. 31.
    Dabaja A, Wosnitzer M, Goldstein M. Varicocele and hypogonadism. Curr Urol Rep. 2013;14:309.CrossRefGoogle Scholar
  32. 32.
    Conners WP, Morgentaler A. The evaluation and management of testosterone deficiency: the new frontier in urology and men’s health. Curr Urol Rep. 2013;14:557–64.CrossRefGoogle Scholar
  33. 33.
    Chen X, Yang D, Lin G, Bao J, Wang J, Tan W. Efficacy of varicocelectomy in the treatment of hypogonadism in subfertile males with clinical varicocele: a meta-analysis. Andrologia. 2017;49(10)  https://doi.org/10.1111/and.12778.CrossRefGoogle Scholar
  34. 34.
    Hsiao W, Rosoff JS, Pale JR, et al. Older age is associated with similar improvements in semen parameters and testosterone after subinguinal microsurgical varicocelectomy. J Urol. 2011;185(2):620–5.  https://doi.org/10.1016/j.juro.2010.09.114.CrossRefPubMedGoogle Scholar
  35. 35.
    Bach PV, Najari BB, Goldstein M. Varicocele – a case for early intervention. F1000Res. 2016;5:F1000 Faculty Rev-1792.  https://doi.org/10.12688/f1000research.7179.1.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Elzanaty S, Johansen C. Microsurgical subinguinal varicocele repair of grade II-III lesions associated with improvements of testosterone levels. Current Urology. 2016;10(1):45–9.  https://doi.org/10.1159/000447150.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Vattikuti Urology InstituteHenry Ford HospitalDetroitUSA

Personalised recommendations